Brain State Technologies announces the publication of new scientific paper in Frontiers in PsychologyContinue reading
Author Archive: AZBio
TGen and NAU patent for new pandemic flu test is approved
H1N1 assay benefits patients by helping doctors determine if infections are resistant to available flu treatments
CASIS Releases Request for Information to Enable Disease Model Research on the International Space Station
The Center for the Advancement of Science in Space (CASIS) today released a Request for Information (RFI) that seeks to identify animal models and cell-based models for use on the International Space Station (ISS) U.S. National Laboratory to improve understanding of human disease and drug screening. Based on responses to this RFI, CASIS plans to issue a future Request for Proposals (RFP) that will provide support for flight research on the ISS National Lab seeking to use animal or cell-based models in microgravity for human disease research that benefits life on Earth.Continue reading
The Tin Man gets his heart
TUCSON, Ariz., Oct. 8, 2014 /PRNewswire/ — Randy Shepherd, an Arizona resident nicknamed the “tin man,” has received a donor heart transplant after 15 months of support from the SynCardia temporary Total Artificial Heart. He was transplanted September 15, 2014, by Dr. Zain Khalpey, MD, PhD, director of the Mechanical Circulatory Support Program at University of Arizona Medical Center, and discharged October 8.Continue reading
A Lifetime of Contributions: Medtronic Founder Earl Bakken
The Advanced Medical Technology Association (AdvaMed) bestowed the second annual AdvaMed Lifetime Achievement Award to Medtronic co-founder Earl Elmer Bakken, creator of the first wearable, battery-operated external pacemaker.Continue reading
Eleven Arizona Legislators Recognized as 2014 AZBio Trailblazers
Alston, Brophy McGee, Carter, Dial, Driggs, McCune Davis, Meyer, Pierce, Tobin, Worsley, and Yee recognized for supporting research, education, innovation and the growth of Arizona’s bioscience sector by the Arizona Bioindustry Association.Continue reading
Job Alert: Anayst I, QC Chemistry at Celgene
Title: Analyst I, QC Chemistry-3rd Shift- Phoenix, AZ
Celgene Corporation, recently declared “The #1 Employer in America” by Business Insider, continues to grow! We are a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries – and growing – we look for talented people to grow our business, advance our science and contribute to our unique culture.
Our Phoenix manufacturing site has a need for an experienced QC Chemist for our 3rd shift. This position performs and documents testing to support routine analysis of utility, raw material, in-process, finished product and stability samples. This is an FDA Compliant position and performs shift work as assigned. Approximate shift hours – 3rd Shift 9:00 pm – 7:30 am (M-Th). Daily work hours may occasionally extend to up to 12 hours. on an as-needed basis.
EDUCATION/EXPERIENCE REQUIREMENTS
- Must possess an Associate’s Degree in Science and four years of experience in a regulated, manufacturing environment- cGMP; or Bachelor’s Degree in Science with two years of experience. (Equivalent combination of experience/education is acceptable)
- Must be experienced in operating general analytical instruments during testing (e.g. TOC, Conductivity, PSA)
- Must have a strong ability to operate more advanced instrumentation during testing (e.g. HPLC, GC, ICP)
- Must live in or be willing to relocate to Phoenix, AZ.
Celgene Corporation offers an outstanding total rewards package, including base salary/annual bonus/equity (company stock) and a competitive benefit plan (401k match, etc.).
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.
Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.
Please apply on-line to the posting at: http://bit.ly/1ua5qbf
Celgene’s future has never been brighter. We invite you to explore “The Promise of Celgene” at http://www.celgene.com/PromiseofCelgene.pdf
Valley Fever Drug Treatment Receives Fast-Track Designation by the FDA Under GAIN Act
Arizona Congressmen David Schweikert and Ron Barber were instrumental in helping AZBio Member Valley Fever Solutions receive Fast-Track Designation from the FDA for the potential curative anti-Valley Fever drug nikkomycin Z (NikZ) as a “qualifying infectious disease product” (QIDP) under the GAIN Act, which will help move it into clinical trials and eventually help patients.Continue reading
Flinn Awards Grant to NAU and Flagstaff Medical Center
Flinn Foundation grant to support NAU health partnership
October 2, 20140 Comments
The Flinn Foundation has awarded $200,000 to Northern Arizona University, which will collaborate with Flagstaff Medical Center on a project identifying how and where people in the community get infected with common germs.
“It will be used to link clinical cases of infectious agents to their sources in the community, and projects that are not even conceived at this point will eventually be possible through this work,” said Paul Keim, Regents professor and director of TGEN’s Pathogen Genomics Division.
This project is part of the Translational Health Research Initiative, the formal partnership between NAU and Northern Arizona Healthcare, FMC’s parent company.
“We have identified common goals so that we can work together to improve the health of our communities,” said Mark Carroll, FMC’s interim chief medical officer.
The genome analysis will take place at NAU with continuous consultation with FMC staff, who will help researchers understand the results in the context of a health care setting. This collaboration is expected to improve understanding of exposure to common infections and guide future research efforts to prevent illness.
A critical component of this project is creating a biobank, a collection of tubes in an ultra cold freezer, along with computer files about the specimens. Along with facilitating infectious disease research, the biobank will support future studies and grant submissions.
Robert Trotter, NAU’s associate vice president for Health Research Initiatives, said the THRIVE partnership for community-based health care research could become a model, which could be adopted in other cities and regions.
The Flinn Foundation is a Phoenix-based philanthropic organization, which funds initiatives designed to improve quality of life in Arizona for future generations. The Foundation’s Seed Grants Initiative to Promote Translational Research in Precision Medicine will cover two years of funding for the NAU partnership.